Product NDC: | 52584-605 |
Proprietary Name: | Glycopyrrolate |
Non Proprietary Name: | Glycopyrrolate |
Active Ingredient(s): | .2 mg/mL & nbsp; Glycopyrrolate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-605 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089335 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120220 |
Package NDC: | 52584-605-25 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (52584-605-25) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 52584-605-25 |
Proprietary Name | Glycopyrrolate |
Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (52584-605-25) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 52584-605 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glycopyrrolate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120220 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | GLYCOPYRROLATE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes |